| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 694501 | Null | 0.0181211508101519 | 0.15149341 |
| NSC 743227 | 2-chloro-1-[4-(4-chloro-1-cyclohexyl-2,5-dioxo-2,5-dihydro-1 H-3-pyrrolylamino)phenylcarboxamido]benzene | 0.0181211508101519 | 0.42329755 |
| NSC 746035 | 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone | 0.0181211508101519 | 0.27977163 |
| NSC 753218 | 3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline | 0.0181211508101519 | 0.27912983 |
| NSC 756233 | GW435821X | 0.0181211508101519 | 0.42617605 |
| NSC 9598 | 3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride | 0.0181211508101519 | 0.45433122 |
| NSC 721386 | 5-Fluoro-2'-deoxyuridyl 2-(1,4-naphthoquinonyl)methyl N-methyl-N-(4-chlorobutyl) phosphoramidate | 0.0187206825450445 | -0.10433664 |
| NSC 728323 | 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0187206825450445 | 0.43832493 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0208632511155816 | 0.42529733 |
| NSC 134459 | Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) | 0.0208632511155816 | 0.30549102 |